Investors

"It is so important to find a cure for HIV, so many people are affected and would benefit. We need companies like Enochian Biosciences to pursue this very important goal."

-Hans Peter Kiem, Director of Stem Cell and Gene Therapy Program at Fred Hutchinson Cancer Research Center and Member of Enochian's Scientific Advisory Board

Investors

Our objective is to maximize the value and therapeutic use of our technology platforms
Investor Relations Contact: Stephanie Carrington Stephanie.Carrington@icrinc.com, (646) 277-1282

NASDAQ Markets stock price

Newsletter

Please fill out the fields below to receive more information about Enochian BioSciences.

Fill out my online form.

Upcoming Events

-Enochian presenting at Biotech Showcase 2019 Read more

-Enochian presenting at NobleCon XV, January 27-29

Valuation

Read more

SEC Filings